VIVE Chart
- 52-Week Range: $0.75 - $2.97
- Market Capitalization: $8.73M
- Short Percentage: 0%
- Target Price: $5.75
- Shares Outstanding: 10.62M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
VIVE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 12th
- Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 17th
- Viveve Reports Full Year 2021 Financial Results and Provides Corporate UpdateAccesswire | March 17th
- Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 11th
- Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in AustraliaAccesswire | September 23rd
- Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment ConferenceAccesswire | September 7th
- Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha | August 12th
Company Info
Website: https://www.viveve.com
Address: Building B, Englewood, CO, United States, 80112
Sector: Healthcare
Industry: Medical Devices
Full time employees: 47
Address: Building B, Englewood, CO, United States, 80112
Sector: Healthcare
Industry: Medical Devices
Full time employees: 47
$VIVE HODL!!!
$VIVE run it!
$VIVE whats the target for Friday close?
$VIVE i need more
$VIVE day trade is ok to buy here but sell later
$VIVE one of the poorest performed stocks for a big name.
$VIVE the price is wrong
$VIVE looking ready to breakout soon.
$VIVE Keep up the pressure.
$VIVE Fake dip news.